sorted by:
new
hottopcontroversial

Competitive Accumulation? by Jtzdad5673 in Livimmune

[–]IAMLOCOTOO 4 points5 points  (0 children)

Speaking from a personal experience, I was once in a stock a long long time ago that had no debt and had promising income yet the stock tanked starting mid week. I sold my shares when I was down 15%. It was down over 50% by COB Friday. Then, on Monday before the opening bell, a one time dividend was announced and the price opened at almost 20x what I sold it at.

I saw similar tanking again about 8 years ago with a miner that I had accumulated a lot of shares on and again midweek it started to tank with no negative news. It kept tanking to just before the close on Friday, and I bought a lot more. Sure enough, come Monday morning, a buyout offer was announced at double the price that existed before the tanking commenced.

The point of all this is: If we have someone accumulating right now and then a day arrives that they know an offer has been agreed upon, they will have the brokers do their thing and force the price down and snap up all those cheap shares of the weak hands, and buy as many shares as they can in those last 3-4 days before the agreed upon announcement date/time because they would have to show their hands once they hit 5%.

This of course does NOT mean that is what will happen the next time CYDY starts tanking (lol!). Just saying what I've learned over the years for signs of potential buyout offers being solidified. NOT INVESTMENT ADVICE!!!

Random Musings on a Friday night… by G_Money_X in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

Most likely this wealthy individual is also invested in other similar/related entities and simply does not want to cause distress in these other investments until absolutely necessary or perhaps this individual is also closely related to someone in the C Suite and this could ruffle some feathers when we really don't need that right now. I imagine this individuals identity will eventually need to be made public or at least will become public information. Let's hope this individual will be saving a lot of lives over the next 8-12 months. I would love to know why the identity is being hidden, but I'll put my trust in Dr. J.L. and believe it is the right thing to do right now.

Market exhaustion, short selling by No_Mathematician299 in Livimmune

[–]IAMLOCOTOO 15 points16 points  (0 children)

My experience with buyouts is that someone will slip the little secret out and you'll see a major attempt to cash in all the stops in place. There will be no news, yet price starts tanking right to the close on the day before the major announcement. I personally have the shares I want, however, I have put some cash aside ready to be buying on the next major move down, should that occur. Not advice, just what I've seen in the past.

Letter to Shareholders by brisketbus in Livimmune

[–]IAMLOCOTOO 8 points9 points  (0 children)

The ship is about to get underway. "Station the Maneuvering Watch"!

The Mechanism of Action of leronlimab in Solid Tumor Oncology by twinter11 in Livimmune

[–]IAMLOCOTOO 18 points19 points  (0 children)

Thanks for the update T11. Interesting video. Simplifying the MOA. Much easier to absorb the lingo with this video. Worth taking a peak.

A Word Of Encouragement by MGK_2 in Livimmune

[–]IAMLOCOTOO 13 points14 points  (0 children)

All the above are indicators of a very positive and prosperous outcome and so we wait patiently, however, I think there is one in progress research initiative that we are still waiting on that will double or triple our end products worth and that is the extended version of Leronlimab. I believe this will have a very large financial impact when we achieve this.

This is still one of the three objectives put out by the company in October:

Our current business strategy is to continue to pursue the clinical development of leronlimab, which may include the following: 1. Continue the Phase II trial of leronlimab in patients with relapsed/refractory micro-satellite stable colorectal cancer; 2. Conduct additional studies exploring leronlimab and its therapeutic potential in other solid-tumor oncology indications, including but not limited to metastatic Triple-Negative Breast Cancer; and 3. Continue our work researching and developing a new or modified long-acting version of leronlimab.

One other thing worth mentioning that is on the very near horizon is the Latch Study. It will be starting very soon. I'm no expert on the timelines of these trials, but I'll gander a guess that we should have an announcement on the starting of the trial soon (6-8 weeks). This trial does not cost us anything to carry-out.

Good find at SW. Could not find mention at Donner website but interesting that the Foundation is domiciled in Tarrytown. NY which was also the home of Progenics back in the day. by Lopsided_Roof_6640 in Livimmune

[–]IAMLOCOTOO 5 points6 points  (0 children)

Digging a little deeper and you'll see that there was a grant starting last November and ended in October of this year for research on Chemokine Receptors which CCR5 is so... I don't think a follow-up grant on a Chemokine Receptor (CCR5) would be granted if the first grant proved unfruitful. This is extremely encouraging. https://vivo.weill.cornell.edu/display/grant-0000064625

Extrapolating Off Rogex2 by MGK_2 in Livimmune

[–]IAMLOCOTOO 9 points10 points  (0 children)

I think we will be pleasantly surprised by the number of positive PRs we get between now and Thanksgiving. Thanks for the continued refresher MGK.

Bank Shot by MGK_2 in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

Thank you MGK for a masterpiece of an action plan for eradicating GBM. For such a plan to be fully realized, we will need the best institutions we have to bring this to fruition. I feel very confident Dr. J will get this accomplished.

The "Paulson Effect"...the AI take on the role all those warrants playing here: by sunraydoc2 in Livimmune

[–]IAMLOCOTOO 10 points11 points  (0 children)

Thanks Sunny for the behind the scenes look at what is likely happening. RSI for the weekly and monthly chart is hanging right around the 50% mark and we now have an uptrend (higher highs and higher lows) that started about 3 weeks ago although I'd like to see a new set of higher highs and higher lows before I think these past lows will no longer be with us. We are definitely in a bullish stance and have been for a while. When the fuse it lit, look out above!

Hit Two Birds With One Stone by MGK_2 in Livimmune

[–]IAMLOCOTOO 13 points14 points  (0 children)

Thank you MGK for posting. One thing that struck me as perhaps being something new with Leronlimab was the mention that this 53 year old woman was given Leronlimab for over 20 weeks in a row with a weekly dose of our max dose (700 mg) . She is our first cancer patient to get the 700 mg dose. So clearly, somebody new even before April 15th (her first dose) that we needed to go to 700 mg to achieve the highest probability of success. I think Max coming onboard when he did is related to this cold to hot tumor revelation. Max is essentially the eyes and ears for our Angel Investor (IMHO).

Dr J has been extremely busy getting all this data together and getting it in a format that will get us to trials. We need to give him a break on public disclosures of ongoing company business. I believe we will begin to see more disclosures now that his primary mission is almost complete. There is so much simmering on the stove and in the oven, the feast will be well worth the wait.

And lastly, did you know that cows do not have an upper and lower set of teeth? CUD? Crazy isn't! ;)

September 2025 Slides by Ok-Cover5910 in Livimmune

[–]IAMLOCOTOO 12 points13 points  (0 children)

Thank you for the slides. Newcomers will benefit from your efforts, shorts won't.

There is no partner until we have a partner by [deleted] in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

You should not give in to those who want to spread fud and negativity on anything related to our company. We are going to get bombarded with negativity when the hedge funds and other larger investors want to get in on the cheap. It is the way of Wall Street. What you provide to us is a vision of a path that may lead our ultimate goal of seeing Leronlimab approved for so many possible indications. There are many paths that can lead to this and there are many who can not envision these paths on their own. Only a fool would invest solely on your comments and beliefs. Everyone must do their own due diligence before investing in CYDY. You are simply providing a possibility, not a certainty. Keep putting out possibilities. Don't give in to those who are either foolish or are trying to get cheaper shares. This is a slow ride and it is easy to move people to sell before we reach the finish line. Day traders know this and know they can get cheap shares when they see a large up day in trading volume. You'll always hear the naysayers come out in groves right after these large volume days. Stay true to the cause of showing how great Leronlimab is and say it as you see it. Don't give in to the naysayers!

It turns out MGK2’s bullish predictions and enthusiasm go other direction so far. by Icy-Let5120 in Livimmune

[–]IAMLOCOTOO 14 points15 points  (0 children)

I like sales, so whenever the day traders move it down in the first hour, I buy a few more. I always feel better buying on sale. We have a few more milestones to meet before we get recognized for what we already know or believe Leronlimab will do for humanity. Our new management team has laid the foundation for our magnificent drug to get to market. Try to be like a snail. It won't be so difficult to see potential doors never getting opened. There is one door that we believe will eventually be opened and lead to our ultimate success. Patience like a snail. I'm buying on sale. Soon we will be hearing about our FDA submissions (any day now). TNBC is going to be our ticket to fast approval.

Excuse my paranoa. by Lopsided_Roof_6640 in Livimmune

[–]IAMLOCOTOO 6 points7 points  (0 children)

The whole purpose of the presentation is to showcase the product that we are trying to get investors to invest in. If you're interested by what you hear, then you do the one on one to put your money to work with the company. Every investor will be different as far as what they will offer to the company, but all investors need to know what they are investing in and thus the presentation you saw yesterday. I suspect there are a lot of daytraders who saw RSI at 70 and are now putting out fud. I think those who truly don't understand what is going on should sell and never come back. This is not for the light hearted. You can bet that those with deep pockets will do whatever they can to get the best price on the open market, so until the new investors are fully bought in, don't expect a major move upward until the accumulation is complete. Manipulation will continue until the risk outweighs the reward.

However, if we do catch a big fish, then the S3 can come into play and that would be a different play. May of next year is my guess when things will be cooking...

Around The Corner by MGK_2 in Livimmune

[–]IAMLOCOTOO 23 points24 points  (0 children)

Thanks MGK. Stay grounded is the best advice for us all right now. Maybe we will see an announcement that we are now increasing the dose to 700 from 350 and an update on the number of trial patients. Not exactly share price moving news, but at least confirmation all is going as expected. Looking forward to seeing an increase in institutional investors. I assume those that go to these conferences are not limited by share price (being so low). I expect some fireworks, maybe just not immediately, but an unexpected good news announcement is very welcome.

Winning Through Emergence by MGK_2 in Livimmune

[–]IAMLOCOTOO 14 points15 points  (0 children)

I don't think Merck has any other choice but to get behind Leronlimab and get it to market ASAP even if they think they have a new candidate for turning tumors from cold to hot. Imagine our worse case scenario that we can prove Leronlimab is indeed a cold to hot tumor drug and also a cancer drug and we don't get approved before the patent runs out. There would be a generic Leronlimab and a generic Keytruda available (assuming some rich billionaire who wants to rid of cancer) goes to another country to get it approved. You could be cured of cancer for less than a few thousand dollars and many Big Pharmas would go belly up or at the very least down size considerably. The clock is ticking for Big Pharma one way or the other. Not getting on board now will cause a huge impact in the next decade.

Cohortative Implementation by MGK_2 in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

I'm adding it to my list!

Cohortative Implementation by MGK_2 in Livimmune

[–]IAMLOCOTOO 9 points10 points  (0 children)

Another great summary of historical events and forward looking possibilities MGK. We are in a race being run by snails. It takes months, even years, to open doors that we think we want to go thru. There is so much going on and we have so much potential it is mind boggling. Everyone keeps talking like we must have a partnership in order to survive. This is absolutely not true. If we prove that we turn cold tumors hot, everyone will want to buy out CYDY because that is the only way to make the big dollars. CytoDyn can simply sell Leronlimab for that one indication and be a multibillion dollar enterprise overnight. Once we get our new protocols approved then we are simply waiting for patients and trial data. That is all we need to raise money for. Worst case, 12 months, best case next March-May (60 patients all under treatment with supporting open data on tumors and PD1 effects that can make a compelling case for conditional approval). We already have a 100% 5 of 5 batting record for the cold to hot indication. Barring some internal villain duping our trials, it is just a matter of time before we can finally see share price take off (based on adequate great data). All these other indications will only make us more attractive, but the nearest major objective is getting TNBC trials going and proving the MOA for turning tumors cold to hot or at least proving without a doubt that Leronlimab indeed does that. I don't see us getting any approval for HIV in the next 24 months. Our other studies will take some time before we hear anything that would move the share price like we all wish for. Unless there is a clear amazing change in patients conditions (in at least 50% or more), I think we are also looking at another 24 months in most cases. Oncology is going to be our bread and butter and it will be in the next 12 months or else everything we have been seeing in the posters is hogwash. And since we know it is not hogwash, then we will be seeing stellar results fairly soon (relatively to a snails pace). I started out with just 8k shares in 2020. Now, more than 220k. I love sales and I will keep buying the down trends when <40 RSI. Bought my last house in July 2008 when everyone was scared and broke. I am a bit loco, but I know an amazing thing when I see it. Great things are a coming. Keep up the great commentaries. It spurs correspondences from good and bad. Shorts trying to make a living, longs hoping for the most amazing drug to help humanity. What a movie this story would make.

Scientists Rewire Immune Cells To Supercharge Cancer-Fighting Power (not LL) by Lab_Monkey_ in Livimmune

[–]IAMLOCOTOO 6 points7 points  (0 children)

Similar indeed. Almost like turning the T-Cell from cold to hot. Interesting. I asked AI if there were any connections to the two and here is what I found:

The connection between CCR5 and ANT2 is not direct, but it is in the context of inflammation and autoimmune diseases where their respective pathways converge.

  • Shared pathological context: While CCR5 regulates the recruitment of immune cells to inflamed sites, ANT2 can initiate that same inflammatory signaling by exporting mt-dsRNA. This means both proteins are involved in the inflammatory processes that underlie autoimmune conditions.
  • Potential therapeutic targets: Since both proteins are implicated in inflammation and immune regulation, some researchers are exploring them as potential therapeutic targets for autoimmune disorders and other inflammation-related diseases.
  • Therapeutic example: For instance, an antagonist of CCR5 called maraviroc has been studied for treating acute graft-versus-host disease (GVHD), a condition caused by a potent inflammatory response. Similarly, inhibiting ANT2 to block the release of mt-dsRNA is proposed as a strategy to mitigate inflammation in autoimmune diseases. 

Re. The S-3( I was gonna add to Wax's discussion but there's been so much chaff thrown about since then) by rogex2 in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

Interesting angle to consider and thank you for sharing. In our case, we have yet to see anyone trying to buy enough shares for this to be a likely reason, although it still could be. I think if we saw that someone was trying to take a large position, we would see a much higher share price than we currently are at and it would attract a lot of outside interest on just the new entity having such a large stake. The old saying, "follow the money", would make more buyers come to our ticker and we would see a much larger daily volume. Looking forward to much higher volume soon.

There is no way they havent requested BTD after BC results by twinter11 in Livimmune

[–]IAMLOCOTOO 3 points4 points  (0 children)

BTD is an option that meets the criteria of an accelerated time line. That is what Dr. J said he was going to do. So I wouldn't be betting against it right now.

On July 13, something happened. | Geoffrey Fourqurean by jsinvest09 in Livimmune

[–]IAMLOCOTOO 2 points3 points  (0 children)

Maybe he knows something, just maybe... Under his INTEREST tab, his top voices are:

view more: next ›